Point-of-Care Testing for COVID-19
The Character of Rheumatology Has Changed Over the Past 50 Years
The History of ACE Inhibitors in Scleroderma Renal Crisis
The ARP Revises Its Fundamentals of Rheumatology Course
The Effects of IL-17A Inhibitors on the Microbiota
Updated Clinical Practice Guidelines for Lyme Disease, Lyme Arthritis
The Unapproved-Drugs Initiative Is Coming to an End
A New $1 Million Endowed Chair Honors Dr. Richard M. Silver
Research Coordinators Offer a Lot to Clinical Rheumatology Research Teams
Case Report: Hydralazine-Induced ANCA-Associated Vasculitis
Study Finds Renal Arteriosclerosis Is Common in Lupus Nephritis Patients
Diagnostic Drill-Down: New Research Suggests Genetic Autoinflammatory Roots
Late-Breaking Abstract Session Spans the Realm of Drug-Related Research
MRI & Axial Spondyloarthritis: Experts Discuss Controversies in the Diagnostic Evaluation of axSpA
Smart, Stem Cell-Based Implants May Revolutionize the Treatment of Arthritis
B Cell Depletion: The Latest Information on Disease Processes, Therapies
Tell a Convincing Story: Tips from the Experts on How to Secure Research Grants
Interfering with Interferon: Experts Discuss IFN Signaling & IFN Inhibition Treatment Possibilities
The Psychosocial Toll of COVID-19
Case Report: Drug-Induced Lupus & ANCA-Associated Vasculitis Overlap
Study Finds NSAIDs Raise Heart Disease Risk in Osteoarthritis Patients
The ACR’s 2020 Advocacy Year in Review
Reporting & Other Tips for the CARES Act Provider Relief Fund
Rheum After 5: Dr. Angus Worthing, the Singing Rheumatologist
Risankizumab May Improve Symptoms of PsA